Jennica Kahkejian, MD
Family Practice · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kahkejian’s office at (408) 851-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A179740 · Current
Licensed to practise in California · since 2022 · expires 2028-08-31 · University of Illinois College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$1,403 in 2024
Medicaid paid $1,403 for 25 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $1,403 |
| TOBACCO NON-USER | 12 | $0 |
| 2024 | 25 | 2 | 12 | $1,403 |
| 2022 | 28 | 1 | 16 | $0 |
See the largest Medicaid services in earlier years
2022
| Return visit (30+ min) | 28 | $0 |
Drugs they prescribed that Part D paid
$78,542
Pharmacies billed $78,542 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,183 generic and 168 brand-name prescriptions · $78,542 in drug cost · 47 antibiotic prescriptions to 26 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 37 | $27,367 | $740 |
| Jardiance | 29 | $15,115 | $521 |
| Insulin Glargine-Yfgn | 14 | $1,494 | $107 |
| Atorvastatin | 115 | $1,299 | $11 |
| Levothyroxine | 47 | $870 | $19 |
See all 32 drugs
| Ozempic | 37 | $27,367 | $740 |
| Jardiance | 29 | $15,115 | $521 |
| Insulin Glargine-Yfgn | 14 | $1,494 | $107 |
| Atorvastatin | 115 | $1,299 | $11 |
| Levothyroxine | 47 | $870 | $19 |
| Losartan | 71 | $841 | $12 |
| Gabapentin | 56 | $759 | $14 |
| Lisinopril | 49 | $611 | $12 |
| Fluticasone Propionate | 30 | $545 | $18 |
| Amlodipine Besylate | 44 | $497 | $11 |
| Metformin | 52 | $482 | $9 |
| Albuterol Sulfate Hfa | 21 | $341 | $16 |
| Hydrochlorothiazide | 29 | $340 | $12 |
| Glipizide | 27 | $300 | $11 |
| Simvastatin | 19 | $215 | $11 |
| Pantoprazole | 17 | $210 | $12 |
| Metoprolol | 20 | $209 | $10 |
| Alendronate | 20 | $196 | $10 |
| Trazodone | 16 | $190 | $12 |
| Metformin Hcl Er | 27 | $190 | $7 |
| Furosemide | 17 | $189 | $11 |
| Tamsulosin | 15 | $175 | $12 |
| Rosuvastatin | 17 | $168 | $10 |
| Famotidine | 14 | $162 | $12 |
| Atenolol | 14 | $150 | $11 |
| Losartan-Hydrochlorothiazide | 12 | $143 | $12 |
| Metoprolol | 12 | $133 | $11 |
| Naproxen | 11 | $112 | $10 |
| Ondansetron Odt | 12 | $110 | $9 |
| Meloxicam | 15 | $94 | $6 |
| Sulfamethoxazole-Trimethoprim | 13 | $87 | $7 |
| Prednisone | 11 | $77 | $7 |
Year by year
| 2024 | 1,373 | 202 | None | 12% | $78,542 |
| 2023 | 662 | 168 | None | 10% | $23,074 |
| 2022 | 468 | 113 | None | 12% | $18,960 |
| 2021 | 164 | 57 | 0% (0) | 14% | $3,776 |
| 2020 | 28 | None | 0% (0) | None | $1,404 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Pradaxa | 17 | $5,014 | $295 |
| Atorvastatin | 55 | $617 | $11 |
| Losartan | 39 | $463 | $12 |
| Bisoprolol | 14 | $415 | $30 |
| Amlodipine Besylate | 35 | $396 | $11 |
| Lisinopril-Hydrochlorothiazide | 26 | $291 | $11 |
| Levothyroxine | 15 | $289 | $19 |
| Rosuvastatin | 32 | $270 | $8 |
| Metformin | 27 | $268 | $10 |
| Sertraline | 20 | $262 | $13 |
| Gabapentin | 12 | $222 | $18 |
| Gemfibrozil | 11 | $196 | $18 |
| Glipizide | 16 | $187 | $12 |
| Hydrochlorothiazide | 12 | $157 | $13 |
| Diltiazem | 11 | $146 | $13 |
| Alendronate | 14 | $139 | $10 |
| Lisinopril | 14 | $137 | $10 |
| Metformin Hcl Er | 17 | $130 | $8 |
| Spironolactone | 12 | $112 | $9 |
| Omeprazole | 12 | $84 | $7 |
2022: 12 drugs
| Amlodipine Besylate | 35 | $376 | $11 |
| Atorvastatin | 27 | $315 | $12 |
| Lisinopril-Hydrochlorothiazide | 22 | $267 | $12 |
| Gabapentin | 12 | $263 | $22 |
| Simvastatin | 16 | $179 | $11 |
| Metformin Hcl Er | 15 | $133 | $9 |
| Hydrochlorothiazide | 13 | $133 | $10 |
| Metformin | 12 | $123 | $10 |
| Losartan | 11 | $117 | $11 |
| Rosuvastatin | 11 | $95 | $9 |
| Omeprazole | 13 | $94 | $7 |
| Meloxicam | 11 | $71 | $6 |
2021: 1 drug
| Amlodipine Besylate | 13 | $150 | $12 |
Professional record
- NPI
- 1093342461
- Licence
- CA A179740California A179740: Current · expires 2028-08-31
- Trained
- University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb), 2020
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 710 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2020-03-25
- NPI last updated
- 2023-09-15
- NPI record certified
- 2023-06-27
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.